Connect Sign In
In the early days of the COVID-19 pandemic, employees at ARUP Laboratories and the University of Utah were first responders to the emerging crisis as they raced to validate tests and build much-needed testing capacity.
At this point in the COVID-19 pandemic, regardless of which combination of vaccinated, boosted, and/or naturally infected we claim, all of us who have developed antibodies against SARS-CoV-2 have the same questions: Are we immune to infection, and if so, how long will that immunity last?
Lisa O’Brien looked at her heart monitor in disbelief. During the past several weeks, she’d had erratic heart rates that varied tremendously from 30 beats per minute (bpm) to the dangerously high number that she stared at now: 220 bpm.
May 17, 2022: The first case of monkeypox is confirmed in the United States in Boston, Massachusetts. May 30, 2022: The CDC releases a test procedure for labs interested in pursuing validation for a laboratory-developed test (LDT).
Marc Couturier, PhD, has always understood the potentially devastating consequences of an infection, whether it’s an isolated case or a pandemic that affects millions.
The impact was almost immediate. The brick-and-mortar healthcare model that defined healthcare delivery for generations could not be sustained during the coronavirus pandemic. Given the elevated risks of COVID-19, healthcare providers and patients were forced to embrace a virtual care model that…
